Indivior Competitors and Similar CompaniesClear all
Indivior's competitors and similar companies include VistaGen Therapeutics, Neurolixis, Newron Pharmaceuticals and EncepHeal Therapeutics.
 Indivior Indivior is a pharmaceutical company focused on developing treatments for substance use disorders and mental health conditions. |  VistaGen Therapeutics VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products. |  Newron Pharmaceuticals Newron Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of central nervous system disorders and pain. |  EncepHeal Therapeutics EncepHeal Therapeutics is a company that develops therapies for cocaine and methamphetamine addictions. | ||
Founding Date | Founding Date 2014 | Founding Date 1998 | Founding Date 2011 | Founding Date 1999 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Kingston upon Hull, GB HQ | Locations South San Francisco, US HQ | Locations HQ | Locations Milano, IT HQ Bresso, IT Stockholm, SE Zürich, CH Morristown, US | Locations Winston-Salem, US HQ Winston Salem, US |
Employees | Employees 1,0946% decrease | Employees 9 | Employees 5 | Employees 22 | Employees 1 |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.2b (FY, 2025) | Revenue (est.) $486k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €19.1m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $233m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $1b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit €19.1m (FY, 2025) | Gross profit N/A |
Net income | Net income $210m (FY, 2025) | Net income ($51.4m) (FY, 2025) | Net income N/A | Net income (€13.2m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 15k (almost 13 years ago) | Latest funding round N/A | Latest funding round $ 150k (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 10m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 150k |
For sources of this data, please see the company profile
View Company Profiles
VistaGen Therapeutics
HQ
South San Francisco, US
Employees
9
VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products.
View companyNewron Pharmaceuticals
HQ
Milano, IT
Employees
22
Newron Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of central nervous system disorders and pain.
View companyEncepHeal Therapeutics
HQ
Winston-Salem, US
Employees
1
EncepHeal Therapeutics is a company that develops therapies for cocaine and methamphetamine addictions.
View company